Malaria Prevention in Pregnancy: When Will the Prevention Programme Respond to the Science

By Steketee, Richard W. | Journal of Health Population and Nutrition, March 2002 | Go to article overview
Save to active project

Malaria Prevention in Pregnancy: When Will the Prevention Programme Respond to the Science


Steketee, Richard W., Journal of Health Population and Nutrition


The article by Okoko and colleagues (1) in this issue of the Journal presents an interesting scenario. By its title, the article draws attention to the comparison with seminal work done between 1966 and 1972 when Sir Ian McGregor and colleagues monitored malaria infection at delivery and birth outcomes in more than 6,000 women in urban and rural parts of western Gambia (2). In a much smaller sample of women delivering during the rainy season in eastern Gambia in 1997, Okoko and colleagues observed very similar findings. In essence, nothing has changed in the 30 intervening years.

The article by McGregor and colleagues, in combination with similar reports by others (3), led to discussions of the importance and appropriate approaches to the prevention of malaria in pregnancy. The World Health Organization (WHO) published recommendations for antimalarial chemoprophylaxis in pregnancy in 1986 (4) and noted the importance of an initial treatment dose, because many asymptomatic women were infected at the time of their first antenatal clinic visit. Studies elsewhere in Africa in the 1980s and 1990s showed the benefit of various treatment and or chemoprophylaxis regimens on the reduction of malaria, maternal anaemia, low birth-weight, and premature delivery (5,6). Work by others in the Gambia contributed to the growing recognition that effective interventions, including the use of antimalarial drugs (7,8) and insecticide-treated bednets (9), could be applied and could markedly reduce the adverse effects from malaria. Yet, good scientific inquiry and published articles have not led directly to changes in national policy and implementation of these policies at the local level. Okoko and colleagues note in their introduction that "the use of antimalarial chemoprophylaxis is still not uniformly practised in the Gambia," and they conclude that "a workable policy needs to be put in place."

Recent studies in African settings have addressed the issue of a 'workable policy.' With the recognition that health systems have difficulty in delivering regular chemoprophylaxis to pregnant women (10), investigators in several settings demonstrated that intermittent preventive treatment (IPT) with effective and safe antimalarial drugs can achieve important reductions in frequency of malaria and its consequences (11,12). These interventions can be particularly cost-effective (13) and reduce the intolerable burden of malaria in pregnancy. The 20th WHO Expert Committee Report recommends, "intermittent treatment with an effective, preferably one-dose antimalarial drug delivered in the context of antenatal care should be made available to primi- and secundigravidae as an appropriate and effective method for reducing the consequences of malaria in pregnancy in highly-endemic areas." In follow-up of this guidance, dialogue between the malaria community and the reproductive health community is underway with the intent to incorporate the malaria-prevention strategy into antenatal care programmes widely in malarious areas of sub-Saharan Africa and to assure necessary supplies of drugs. Like all proven and important public-health prevention strategies, this will need continued attention and much advocacy from the malaria and reproductive-health community, and advocacy and demand from the mothers (and their babies) who will benefit.

This approach using IPT has been facilitated by having sulphadoxine-pyrimethamine (SP) *, an antimalarial therapy that still has good efficacy in these semi-immune women, is a single-dose treatment, is not bitter, and is relatively well-tolerated. Importantly, studies of IPT with SP in pregnancy in numerous settings have clearly demonstrated its efficacy and effectiveness in programmes (6). Because of the single-dose treatment, the effectiveness of the programme essentially matches the efficacy of the drug as long as health workers can give it under observation in the clinic. If and when we have to move from SP to alternative drugs or drug combinations that require multi-day dosing, this will be more challenging (i.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Malaria Prevention in Pregnancy: When Will the Prevention Programme Respond to the Science
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?